IPSC
Price
$0.57
Change
-$0.00 (-0.00%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
49.54M
16 days until earnings call
OCGN
Price
$1.01
Change
-$0.01 (-0.98%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
294.95M
10 days until earnings call
Interact to see
Advertisement

IPSC vs OCGN

Header iconIPSC vs OCGN Comparison
Open Charts IPSC vs OCGNBanner chart's image
Century Therapeutics
Price$0.57
Change-$0.00 (-0.00%)
Volume$2.03K
Capitalization49.54M
Ocugen
Price$1.01
Change-$0.01 (-0.98%)
Volume$18.3K
Capitalization294.95M
IPSC vs OCGN Comparison Chart in %
Loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. OCGN commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and OCGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (IPSC: $0.57 vs. OCGN: $1.02)
Brand notoriety: IPSC and OCGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 66% vs. OCGN: 47%
Market capitalization -- IPSC: $49.54M vs. OCGN: $294.95M
IPSC [@Biotechnology] is valued at $49.54M. OCGN’s [@Biotechnology] market capitalization is $294.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileOCGN’s FA Score has 0 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • OCGN’s FA Score: 0 green, 5 red.
According to our system of comparison, OCGN is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 4 TA indicator(s) are bullish while OCGN’s TA Score has 4 bullish TA indicator(s).

  • IPSC’s TA Score: 4 bullish, 5 bearish.
  • OCGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both IPSC and OCGN are a bad buy in the short-term.

Price Growth

IPSC (@Biotechnology) experienced а -5.01% price change this week, while OCGN (@Biotechnology) price change was -10.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.19%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +33.92%.

Reported Earning Dates

IPSC is expected to report earnings on Nov 06, 2025.

OCGN is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCGN($295M) has a higher market cap than IPSC($49.5M). OCGN YTD gains are higher at: 25.466 vs. IPSC (-43.069). IPSC has higher annual earnings (EBITDA): -5.99M vs. OCGN (-54.34M). IPSC has more cash in the bank: 165M vs. OCGN (37.8M). OCGN has less debt than IPSC: OCGN (31.8M) vs IPSC (52.7M). IPSC has higher revenues than OCGN: IPSC (115M) vs OCGN (4.52M).
IPSCOCGNIPSC / OCGN
Capitalization49.5M295M17%
EBITDA-5.99M-54.34M11%
Gain YTD-43.06925.466-169%
P/E RatioN/AN/A-
Revenue115M4.52M2,543%
Total Cash165M37.8M437%
Total Debt52.7M31.8M166%
FUNDAMENTALS RATINGS
OCGN: Fundamental Ratings
OCGN
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPSCOCGN
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAPMY0.570.11
+23.55%
Saipem S.p.A.
SKLTY32.130.63
+2.00%
Seek Ltd
HLNCF4.840.07
+1.36%
HALEON PLC
ATBHF0.05N/A
N/A
Aston Bay Holdings Ltd.
ATSKF0.88N/A
N/A
Allied Telesis Holdings KK

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+0.84%
CRSP - IPSC
57%
Loosely correlated
+0.31%
CRBU - IPSC
53%
Loosely correlated
+0.98%
NTLA - IPSC
52%
Loosely correlated
+4.73%
OCGN - IPSC
52%
Loosely correlated
-0.98%
RXRX - IPSC
52%
Loosely correlated
+9.59%
More

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
-0.98%
RAIN - OCGN
53%
Loosely correlated
-0.51%
IPSC - OCGN
51%
Loosely correlated
+0.84%
ARRY - OCGN
47%
Loosely correlated
-3.94%
AXON - OCGN
46%
Loosely correlated
-0.60%
BEAM - OCGN
46%
Loosely correlated
+1.35%
More